185 related articles for article (PubMed ID: 27288300)
1. Polymorphisms of HLA-DQB1 predict survival of hepatitis B virus-related hepatocellular carcinoma patients receiving hepatic resection.
Liu X; Yu L; Han C; Lu S; Zhu G; Su H; Qin W; Liao X; Peng T
Clin Res Hepatol Gastroenterol; 2016 Dec; 40(6):739-747. PubMed ID: 27288300
[TBL] [Abstract][Full Text] [Related]
2. Impacts of human leukocyte antigen DQ genetic polymorphisms and their interactions with hepatitis B virus mutations on the risks of viral persistence, liver cirrhosis, and hepatocellular carcinoma.
Ji X; Zhang Q; Li B; Du Y; Yin J; Liu W; Zhang H; Cao G
Infect Genet Evol; 2014 Dec; 28():201-9. PubMed ID: 25281206
[TBL] [Abstract][Full Text] [Related]
3. Human leukocyte antigen variants and risk of hepatocellular carcinoma modified by hepatitis C virus genotypes: A genome-wide association study.
Lee MH; Huang YH; Chen HY; Khor SS; Chang YH; Lin YJ; Jen CL; Lu SN; Yang HI; Nishida N; Sugiyama M; Mizokami M; Yuan Y; L'Italien G; Tokunaga K; Chen CJ;
Hepatology; 2018 Feb; 67(2):651-661. PubMed ID: 28921602
[TBL] [Abstract][Full Text] [Related]
4. PLCE1 polymorphisms and expression combined with serum AFP level predicts survival of HBV-related hepatocellular carcinoma patients after hepatectomy.
Liao X; Han C; Qin W; Liu X; Yu L; Zhu G; Yu T; Lu S; Su H; Liu Z; Chen Z; Yang C; Huang K; Liu Z; Liang Y; Huang J; Dong J; Li L; Qin X; Ye X; Xiao K; Peng M; Peng T
Oncotarget; 2017 Apr; 8(17):29202-29219. PubMed ID: 28418898
[TBL] [Abstract][Full Text] [Related]
5. Post-ablation des-gamma-carboxy prothrombin level predicts prognosis in hepatitis B-related hepatocellular carcinoma.
Lee S; Rhim H; Kim YS; Kang TW; Song KD
Liver Int; 2016 Apr; 36(4):580-7. PubMed ID: 26503910
[TBL] [Abstract][Full Text] [Related]
6. Better prognosis of hepatic resection combined with antiviral therapy for HBV-related hepatocellular carcinoma with BCLC Stage B/C.
Wei Q; Tian H; Luo HX; Zhang YC; Deng YN; Yao J; Li H; Chen GH; Yang Y
Asian J Surg; 2017 Nov; 40(6):453-462. PubMed ID: 27321176
[TBL] [Abstract][Full Text] [Related]
7. Genetic polymorphisms of immune checkpoint proteins PD-1 and TIM-3 are associated with survival of patients with hepatitis B virus-related hepatocellular carcinoma.
Li Z; Li N; Li F; Zhou Z; Sang J; Jin Z; Liu H; Han Q; Lv Y; Liu Z
Oncotarget; 2016 May; 7(18):26168-80. PubMed ID: 27034168
[TBL] [Abstract][Full Text] [Related]
8. HLA-DQA1 & DQB1 variants associated with hepatitis B virus-related chronic hepatitis, cirrhosis & hepatocellular carcinoma.
Karra VK; Chowdhury SJ; Ruttala R; Gumma PK; Polipalli SK; Chakravarti A; Kar P
Indian J Med Res; 2018 Jun; 147(6):573-580. PubMed ID: 30168489
[TBL] [Abstract][Full Text] [Related]
9. Prognostic value of Notch receptors in postsurgical patients with hepatitis B virus-related hepatocellular carcinoma.
Yu T; Han C; Zhu G; Liao X; Qin W; Yang C; Liu Z; Su H; Liu X; Yu L; Liu Z; Lu S; Chen Z; Liang Y; Huang J; Qin X; Gui Y; Li J; Peng T
Cancer Med; 2017 Jul; 6(7):1587-1600. PubMed ID: 28568708
[TBL] [Abstract][Full Text] [Related]
10. Hepatitis B virus reactivation after radiofrequency ablation or hepatic resection for HBV-related small hepatocellular carcinoma: a retrospective study.
Dan JQ; Zhang YJ; Huang JT; Chen MS; Gao HJ; Peng ZW; Xu L; Lau WY
Eur J Surg Oncol; 2013 Aug; 39(8):865-72. PubMed ID: 23597497
[TBL] [Abstract][Full Text] [Related]
11. Genetic polymorphisms in the Wnt/β-catenin pathway genes as predictors of tumor development and survival in patients with hepatitis B virus-associated hepatocellular carcinoma.
Kim SS; Cho HJ; Lee HY; Park JH; Noh CK; Shin SJ; Lee KM; Yoo BM; Lee KJ; Cho SW; Cheong JY
Clin Biochem; 2016 Jul; 49(10-11):792-801. PubMed ID: 26968103
[TBL] [Abstract][Full Text] [Related]
12. Replication of genome wide association studies on hepatocellular carcinoma susceptibility loci in a Chinese population.
Chen K; Shi W; Xin Z; Wang H; Zhu X; Wu X; Li Z; Li H; Liu Y
PLoS One; 2013; 8(10):e77315. PubMed ID: 24204805
[TBL] [Abstract][Full Text] [Related]
13. Differences in surgical outcomes between hepatitis B- and hepatitis C-related hepatocellular carcinoma: a retrospective analysis of a single North American center.
Franssen B; Alshebeeb K; Tabrizian P; Marti J; Pierobon ES; Lubezky N; Roayaie S; Florman S; Schwartz ME
Ann Surg; 2014 Oct; 260(4):650-6; discussion 656-8. PubMed ID: 25203882
[TBL] [Abstract][Full Text] [Related]
14. Posthepatectomy HBV reactivation in hepatitis B-related hepatocellular carcinoma influences postoperative survival in patients with preoperative low HBV-DNA levels.
Huang G; Lai EC; Lau WY; Zhou WP; Shen F; Pan ZY; Fu SY; Wu MC
Ann Surg; 2013 Mar; 257(3):490-505. PubMed ID: 22868358
[TBL] [Abstract][Full Text] [Related]
15. Impact of viral hepatitis on outcomes after liver resection for hepatocellular carcinoma: results from a north american center.
Lee JJ; Kim PT; Fischer S; Fung S; Gallinger S; McGilvray I; Moulton CA; Wei AC; Greig PD; Cleary SP
Ann Surg Oncol; 2014 Aug; 21(8):2708-16. PubMed ID: 24806113
[TBL] [Abstract][Full Text] [Related]
16. Transarterial chemoembolization versus resection for intermediate-stage (BCLC B) hepatocellular carcinoma.
Kim JY; Sinn DH; Gwak GY; Choi GS; Saleh AM; Joh JW; Cho SK; Shin SW; Carriere KC; Ahn JH; Paik YH; Choi MS; Lee JH; Koh KC; Paik SW
Clin Mol Hepatol; 2016 Jun; 22(2):250-8. PubMed ID: 27377909
[TBL] [Abstract][Full Text] [Related]
17. [Correlation between polymorphisms in the human leukocyte antigen-DQB1 alleles and hepatitis B with primary hepatocellular carcinoma].
Li Q; Li X; Zhang L; Zhao L
Zhonghua Gan Zang Bing Za Zhi; 2015 Apr; 23(4):270-4. PubMed ID: 26133818
[TBL] [Abstract][Full Text] [Related]
18. Recurrence of hepatitis B-related hepatocellular carcinoma is associated with high viral load at the time of resection.
Hung IF; Poon RT; Lai CL; Fung J; Fan ST; Yuen MF
Am J Gastroenterol; 2008 Jul; 103(7):1663-73. PubMed ID: 18616655
[TBL] [Abstract][Full Text] [Related]
19. Genetic polymorphism of HLA-DQ confers susceptibility to hepatitis B virus-related hepatocellular carcinoma: a case-control study in Han population in China.
Gao X; Liu W; Zhang X; Tang L; Wang L; Yan L; Yang H; Li T; Yang L; Ma N; Liu D
Tumour Biol; 2016 Sep; 37(9):12103-12111. PubMed ID: 27209411
[TBL] [Abstract][Full Text] [Related]
20. Genetic variants in human leukocyte antigen/DP-DQ influence both hepatitis B virus clearance and hepatocellular carcinoma development.
Hu L; Zhai X; Liu J; Chu M; Pan S; Jiang J; Zhang Y; Wang H; Chen J; Shen H; Hu Z
Hepatology; 2012 May; 55(5):1426-31. PubMed ID: 22105689
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]